-+ 0.00%
-+ 0.00%
-+ 0.00%

Senseonics Initiates First-In-Human Study Of Freedom

Benzinga·10/26/2026 12:04:52
Listen to the news

First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028

Built on the proven sensing technology behind Eversense 365 and supported by encouraging preclinical data to reduce development risk